Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough. Επικοινωνία Submitted by Στέργιος Πολύζος on Τρί, 11/24/2020 - 11:37
